Key result
Elevated Periostin (POSTN) expression in placenta accreta spectrum disorders promoted endothelial cell proliferation, mobility, and angiogenesis via the Notch signaling pathway in vitro.
Why the study?
Extensive neovascularization is linked to massive blood loss in placenta accreta spectrum (PAS), prompting exploration of related proteins and their regulatory roles.
Elevated POSTN expression in placenta accreta spectrum disorders promotes angiogenesis via Notch signaling, suggesting its potential as a molecular marker for significant intraoperative blood loss.
Identifies candidate proteins in PAS neovascularization; leaves open any clinical or therapeutic role pending validation.
Objective Extensive neovascularization, closely linked to massive intraoperative blood loss, is a pathological hallmark of placenta accreta spectrum (PAS) cases. This study aims to explore proteins related to neovascularization and elucidate their regulatory roles in PAS, enhancing our understanding of this condition.Methods The isobaric tags for relative and absolute quantitation technique were used to identify and quantify the differentially expressed proteins in placentas from PAS and healthy pregnant women. Immunofluorescence staining and western blot analysis were conducted to determine the protein expression and localization. Gain-of-function experiments were used to conduct cell proliferation and migration assays. In addition, the tube formation assay was performed to evaluate angiogenesis in vitro. The Notch inhibitor DAPT was used to determine the involvement of Notch signaling in angiogenesis in PAS.Results Periostin (POSTN) exhibited higher expression in PAS placentas than in normal placentas. Moreover, the overexpression of POSTN in endothelial cells promoted cell proliferation, mobility, and endothelial angiogenesis via the Notch signaling pathway in vitro.Conclusion Elevated POSTN expression in PAS is associated with increased angiogenesis, indicating its potential as a molecular marker for significant intraoperative blood loss.
No takes yet. Share an insight, caveat, or question.
Li et al. (2023) studied Placenta accreta spectrum (PAS) disorders. Periostin (POSTN) expression vs. Normal placentas / control cells was evaluated on Protein expression and in vitro angiogenesis (cell proliferation, mobility, tube formation). Elevated Periostin (POSTN) expression in placenta accreta spectrum disorders promoted endothelial cell proliferation, mobility, and angiogenesis via the Notch signaling pathway in vitro.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: